Updated: Oct 20, 2024
The average Intra-Cellular Therapies stock price target is 97.92 with a max estimate of 130.00 and a min estimate of 79.00
Review Intra-Cellular Therapies earnings estimates
Receive timely notifications of rating changes
View more detailed ratings of institutions and analysts
View rating details page for historical data
Analyst Ratings Disclaimer
Updated: Oct 20, 2024
No Data